Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) is set to release its Q3 2025 earnings on Jan 31, 2025. The consensus ...

Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call. My name ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...

Sun Pharmaceutical Industries Ltd. closed 11.40% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...

It is expected that representatives for MSMEs pharma manufacturers may raise the issue of extension of Revised Schedule M implementation timelines ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

Expert Chahat Aggarwal anticipates a growing pharmaceutical industry backed by government initiatives in the Union Budget ...